Search

Your search keyword '"Shaojun Zhu"' showing total 236 results

Search Constraints

Start Over You searched for: Author "Shaojun Zhu" Remove constraint Author: "Shaojun Zhu"
236 results on '"Shaojun Zhu"'

Search Results

1. Research on an artificial intelligence-based myopic maculopathy grading method using EfficientNet

2. MTS-YOLO: A Multi-Task Lightweight and Efficient Model for Tomato Fruit Bunch Maturity and Stem Detection

3. Application and visualization study of an intelligence-assisted classification model for common eye diseases using B-mode ultrasound images

4. Prediction of spherical equivalent refraction and axial length in children based on machine learning

5. Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225

6. Synergistic regulation of hydrophobicity and basicity for copper hydroxide‐derived copper to promote the CO2 electroreduction reaction

7. Intermuscular coupling network analysis of upper limbs based on R-vine copula transfer entropy

8. Classification of dry and wet macular degeneration based on the ConvNeXT model

9. Automated measurement of the disc-fovea angle based on DeepLabv3+

10. Systematic Bibliometric and Visualized Analysis of Research Hotspots and Trends on the Application of Artificial Intelligence in Ophthalmic Disease Diagnosis

11. Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol

12. Injectable Self-Healing Adhesive pH-Responsive Hydrogels Accelerate Gastric Hemostasis and Wound Healing

13. Discontinuation of aspirin before non-cardiac surgery causing ventricular mural thrombus for a patient with left ventricular aneurysm: a case report

14. Screening of Common Retinal Diseases Using Six-Category Models Based on EfficientNet

15. Retinal Image Enhancement Using Cycle-Constraint Adversarial Network

16. The Local Definability of Robotic Large-Scale Knowledge Based on Splitting

17. CD147 expression in human gastric cancer is associated with tumor recurrence and prognosis.

18. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.

32. Exosomal miR-181a-3p Regulates the Anlotinib Resistance of Lung Cancer Cells

35. Supplementary Methods, Figures 1-9 from An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

36. Data from An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

37. Interview with Dr. Mischel from Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance

38. Supplementary Figures 1-13, Tables 1-2 from Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance

39. Supplementary Material from Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance

40. Interview with Dr. Mellinghoff from Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

41. Supplementary Figures 1-10 from Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

42. Supplementary Tables 1-8 from Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

43. Supplementary Figure and Table Legends, Methods from Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

44. Supplementary Figure 5 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

45. Data from Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples

46. Supplementary Figure Legend from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

47. Supplementary Figure 2 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

48. Supplementary Figure 1 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

49. Supplementary Figure 3 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

50. Supplementary Data from Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples

Catalog

Books, media, physical & digital resources